“… 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 Less has been published about MCL which is an aggressive subtype of B-cell non-Hodgkin lymphoma that is characterized by a recurrent genetic translocation, t(11;14), involving the gene encoding cyclin D1 in approximately 85% of cases. 14 MCL-associated kidney dysfunction has been documented only in case reports, with authors reporting polyclonal IC mediated GN, 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 C3GN, 24 , 25 and pauci-immune crescentic GN, 26 as well as frequent renal infiltration by lymphoma. 17 , 18 , 19 , 21 , 22 , 23 , 24 , 26 , 27 In this study, we initiated a multi-institutional retrospective review to describe the clinicopathologic spectrum of MCL-associated kidney injury, treatment, and outcomes.…”